The owner of the American Chizmet for Pharmacy in the Street should be taken privately in agreement of $ 10 billion (£ 7.8.
The company operating about 1,900 boots in the UK sold to the American SYCAMORE private capital partner after the internet era because customers turned into an online shopping for cheaper products.
Walgreens’ market capitalization has collapsed by 90% since 2015. years and is now valued on $ 9.3 billion. It has debt and lease commitments of $ 30 billion.
Sycamore partners hit a contract of 11.45 US dollars for the company, giving him the value of the capital of about $ 10 billion.
However, investors could get an additional $ 3 share based on Walgreens sales, “Primary care, Villagemd, business evaluation, including debt, to $ 23.7 billion.
After the conversation in December, if the sale was reported, Sycamore probably retained American retail business and sell or drive out the rest of the business, which includes boots in the UK.
Walgreens first took a share in boots in 2012. years and finished the purchase of two years later. 2020. year, during the coronavirus pandemic, boots said to cut 4,000 jobs, about 7% of the workforce and closed almost 50 branches of opticians.
Two years ago, the chain announced the closure of 300 stores, which was completed at the end of last year, because it “evolved” its shop.
2022. Walgreens set up boots for sale, but later the plans have fallen as potential customers who fought to collect funds.
The agreement will lead to the end of Walgreens in 97 years as listed in the list, although the second largest pharmacy chain still has 35 days for search or entertain rival bids.
As part of the Agreement with Sycamore, the Italian billionaire of Stefano Pessina, the Executive President Walgreens and the largest shareholder, will hold a minority share in the business.
After promoting the newsletter
Pessina bounds the company Transatlantic Pharmacy by joining Walgreens with the USA with allies for 2014. year, she paid 4.3 billion pounds to in 2012. years in 2012.
Walgreens’ market value reached $ 100 billion shortly after the merge end, but it fell in the last decade as e-shop hit its middle trading surgery.
Tim Wentworth, Chief Executive Director Walgreens, said that the company navigala “challenges of rapidly develop pharmacy and increasingly complex and competitive retail landscape”.
He said, “As we progress against our ambitious turning strategy, meaningful creating value will take time. Focus and change that is better managed as a private company.”
2025-03-07 08:24:00